PERI THOMAS: Open Payments
NPI 1669203709 · HERNANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 78 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $239 · 2025 $1,557
Food & beverage: $1,557
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 23 | $269 |
| Alkermes, Inc. | 12 | $257 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $251 |
| E.R. Squibb & Sons, L.L.C. | 3 | $181 |
| ABBVIE INC. | 6 | $127 |
| Vanda Pharmaceuticals Inc. | 4 | $107 |
| Noven Therapeutics, LLC | 3 | $71 |
| Indivior Inc. | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $45 |
Products named: CAPLYTA, REXULTI, ARISTADA, COBENFY, VRAYLAR, FANAPT, SUBLOCADE, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
